Nifty needs to hold 11,100 for further upside: Gaurav Garg of CapitalVia

The likelihood of a short-covering move along with addition of fresh position exists only if Nifty breaches 11,200

stock, market, shares, investment, investors, trading, sensex, growth, technology
Jubilant Life's stock is witnessing resistance breakout from the levels of Rs 760
Gaurav Garg Mumbai
3 min read Last Updated : Jul 27 2020 | 8:25 AM IST
Nifty outlook

The Indian markets traded with mixed sentiments last week and witnessed sharp short covering move from its immediate support level of 11,100. However, the Nifty closed above 11,100 which might act as immediate support level and might be crucial for this week as the monthly expiry is on July 30 (Thursday). On Friday, Nifty managed to close at 11,194.20, slashing 21.30 points. Technology stocks traded with positive sentiments whereas metal, PSU banks and financial stocks closed in the red. Nifty bank closed at 22,662, slashing 421.90 points from the previous day’s closing.

As per weekly option data, handful of call writing can be seen on higher strikes ranging from 11,200 to 11,400 which shows Nifty would face resistance in the sub 11,200 zone. The level of 11,000 might act as support as maximum put open interest (OI) is placed there. We can witness short-covering move along with addition of fresh position only if Nifty breaches 11,200. Therefore, traders should try to create short position keeping a close eye on 11,200.
 
We can see a big momentum in following stocks: 

Buy Jubilant Life Sciences Limited (Above Rs 760) 

Target:  Rs 794

Stop loss:  Rs 735

The stock is witnessing resistance breakout from the levels of Rs 760. It iis forming bullish flag pattern and trading above its important moving averages. Further buying momentum would be witnessed if the stock moves above 760. Considering the technical evidence discussed above, we recommend buying the stock above 760 for the target of Rs 794, keeping a stop loss at Rs 735 on a closing basis.
 
Buy Glenmark Pharmaceuticals Limited (Above Rs 431)

Target: Rs 455

Stop loss: Rs 419

The stock is trading at its resistance placed in zone of 431 and forming reversal pattern on the weekly chart. If, somehow, the stock breaks this level, it might move into the next resistance zone which is placed at 470. The stock is showing signs of strength on hourly charts. Breakout from this level would lead the stock to witness more upward movement. We recommend buying the stock above 431 for the target of Rs 455, keeping a stop loss at Rs 419 on a closing basis.
Disclaimer: Gaurav Garg is Head of Research at CapitalVia Global Research Limited- Investment Advisor. The analyst does not hold position in any of the stocks mentioned above. Views expressed are personal.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Market technicalsMarketsJubilant LifeGlenmark PharmaNifty Outlook

Next Story